These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 26799480)
1. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs. Gelato KA; Adler D; Ocker M; Haendler B Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480 [TBL] [Abstract][Full Text] [Related]
2. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Morera L; Lübbert M; Jung M Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667 [TBL] [Abstract][Full Text] [Related]
3. Targeting Histone Methylation in Cancer. McCabe MT; Mohammad HP; Barbash O; Kruger RG Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430 [TBL] [Abstract][Full Text] [Related]
4. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo. Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576 [TBL] [Abstract][Full Text] [Related]
5. BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer. Genta S; Pirosa MC; Stathis A Curr Oncol Rep; 2019 Feb; 21(2):13. PubMed ID: 30715616 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic small molecule modulators of histone and DNA methylation. Hauser AT; Robaa D; Jung M Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619 [TBL] [Abstract][Full Text] [Related]
8. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma. Bais MV J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer. Hosseini A; Minucci S Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367 [TBL] [Abstract][Full Text] [Related]
11. Targeting LSD1 in cancer: Molecular elucidation and recent advances. Cai W; Xiao C; Fan T; Deng Z; Wang D; Liu Y; Li C; He J Cancer Lett; 2024 Aug; 598():217093. PubMed ID: 38969160 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
13. Emerging epigenetic targets and therapies in cancer medicine. Popovic R; Licht JD Cancer Discov; 2012 May; 2(5):405-13. PubMed ID: 22588878 [TBL] [Abstract][Full Text] [Related]
14. Targeting epigenetic enzymes for autism treatment. Yan Z Trends Pharmacol Sci; 2024 Sep; 45(9):764-767. PubMed ID: 39034229 [TBL] [Abstract][Full Text] [Related]
15. Targeting protein lysine methylation and demethylation in cancers. He Y; Korboukh I; Jin J; Huang J Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):70-9. PubMed ID: 22194015 [TBL] [Abstract][Full Text] [Related]
16. Targeting epigenetic regulators for cancer therapy. Wee S; Dhanak D; Li H; Armstrong SA; Copeland RA; Sims R; Baylin SB; Liu XS; Schweizer L Ann N Y Acad Sci; 2014 Feb; 1309():30-6. PubMed ID: 24571255 [TBL] [Abstract][Full Text] [Related]
17. The emerging roles of histone demethylases in cancers. Tong D; Tang Y; Zhong P Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150 [TBL] [Abstract][Full Text] [Related]
18. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer. Filipp FV Brief Funct Genomics; 2017 Nov; 16(6):320-325. PubMed ID: 28369194 [TBL] [Abstract][Full Text] [Related]